Lind MJ - Search Results

1

Clinical response to primary letrozole therapy in elderly patients with early breast cancer: possible role for p53 as a biomarker.

Garimella V, Hussain T, Agarwal V, Radhakrishna S, Fox JN, Kneeshaw PJ, Long ED, Mahapatra TK, McManus PL, Lind MJ, Drew PJ, Cawkwell L. Garimella V, et al. Among authors: lind mj. Int J Surg. 2014;12(8):821-6. doi: 10.1016/j.ijsu.2014.06.009. Epub 2014 Jul 8. Int J Surg. 2014. PMID: 25010604 Free article.

2

Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?

Agarwal V, Lind MJ, Cawkwell L. Agarwal V, et al. Among authors: lind mj. Cancer Treat Rev. 2011 Nov;37(7):533-42. doi: 10.1016/j.ctrv.2010.11.004. Epub 2010 Dec 22. Cancer Treat Rev. 2011. PMID: 21183281 Review.

3

A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer.

Elfadl D, Hodgkinson VC, Long ED, Scaife L, Drew PJ, Lind MJ, Cawkwell L. Elfadl D, et al. Among authors: lind mj. Breast. 2011 Aug;20(4):334-7. doi: 10.1016/j.breast.2011.02.017. Epub 2011 Mar 15. Breast. 2011. PMID: 21411324 Free article.

4

Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?

Hodgkinson VC, ELFadl D, Agarwal V, Garimella V, Russell C, Long ED, Fox JN, McManus PL, Mahapatra TK, Kneeshaw PJ, Drew PJ, Lind MJ, Cawkwell L. Hodgkinson VC, et al. Among authors: lind mj. J Proteomics. 2012 Feb 2;75(4):1276-83. doi: 10.1016/j.jprot.2011.11.005. Epub 2011 Nov 15. J Proteomics. 2012. PMID: 22115752

5

Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer.

Hodgkinson VC, Agarwal V, ELFadl D, Fox JN, McManus PL, Mahapatra TK, Kneeshaw PJ, Drew PJ, Lind MJ, Cawkwell L. Hodgkinson VC, et al. Among authors: lind mj. J Proteomics. 2012 May 17;75(9):2745-52. doi: 10.1016/j.jprot.2012.03.049. Epub 2012 Apr 3. J Proteomics. 2012. PMID: 22498883

6

Cancer proteomics and its application to discovery of therapy response markers in human cancer.

Smith L, Lind MJ, Welham KJ, Cawkwell L; Cancer Biology Proteomics Group. Smith L, et al. Among authors: lind mj. Cancer. 2006 Jul 15;107(2):232-41. doi: 10.1002/cncr.22000. Cancer. 2006. PMID: 16752413 Free article. Review.

7

The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays.

Smith L, Watson MB, O'Kane SL, Drew PJ, Lind MJ, Cawkwell L. Smith L, et al. Among authors: lind mj. Mol Cancer Ther. 2006 Aug;5(8):2115-20. doi: 10.1158/1535-7163.MCT-06-0190. Mol Cancer Ther. 2006. PMID: 16928833

8

Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.

Watson MB, Lind MJ, Smith L, Drew PJ, Cawkwell L. Watson MB, et al. Among authors: lind mj. Acta Oncol. 2007;46(5):651-8. doi: 10.1080/02841860601156157. Acta Oncol. 2007. PMID: 17562441

9

Establishment of in-vitro models of chemotherapy resistance.

Watson MB, Lind MJ, Cawkwell L. Watson MB, et al. Among authors: lind mj. Anticancer Drugs. 2007 Aug;18(7):749-54. doi: 10.1097/CAD.0b013e3280a02f43. Anticancer Drugs. 2007. PMID: 17581296 Review.

10

The putative roles of the ubiquitin/proteasome pathway in resistance to anticancer therapy.

Smith L, Lind MJ, Drew PJ, Cawkwell L. Smith L, et al. Among authors: lind mj. Eur J Cancer. 2007 Nov;43(16):2330-8. doi: 10.1016/j.ejca.2007.07.023. Epub 2007 Sep 20. Eur J Cancer. 2007. PMID: 17888650 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page